May 16, 2013—The long-awaited regulation to implement health care reform's partial limit on 340B discounts for orphan drugs is back on hold. On May 8, the White House Office of Management and Budget (OMB) reported online that its review of the Health Resources and Services Administration's (HRSA) proposed 340B orphan drug exclusion final rule had been extended. … [Read more...]
Mylan Mails Checks for 340B Overcharges
Refunds are certain products sold from 1994 through 2006May 15, 2013—Drug manufacturer Mylan has mailed refunds to 340B providers for overcharges on all products sold by its Mylan Specialty subsidiary (formerly known as Dey Pharma) from late 1994 through late 2006. Last November, the Office of Pharmacy Affairs (OPA) posted a message from Mylan on its home page explaining that the company needed to give refunds to 340B entities … [Read more...]
Judge Invalidates Calif. 340B Medicaid Carve-in Mandate
Says state ignored statutory and regulatory procedural requirementsMay 7, 2013—A federal district judge has ordered California to stop requiring 340B health care providers to "carve in" all Medicaid patients and to bill the state for 340B drugs given to such patients at actual acquisition cost (AAC). Acting in a case brought by the AIDS Healthcare Foundation (AHF), U.S. District Judge Manuel L. Real issued a permanent injunction on May 3 … [Read more...]
Illinois Fleshes Out 340B Participation Requirement
Regulations and guidelines answer many, but not all, questionsMay 6, 2013—The Illinois Department of Healthcare and Family Services has reversed a decision it made earlier this year to require 340B contract pharmacies to use 340B drugs for Medicaid patients beginning this July. In a recent statement on its website, the department said it was putting the requirement on indefinite hold. "In the contract pharmacy scenario, the pharmacy … [Read more...]
340B Orphan Drug Rule Review Passes 90-Day Mark
HRSA says it is still working with OMB to finalize regulationMay 2, 2013—The Health Resources and Services Administration (HRSA) "is continuing to work" with the White House Office of Management and Budget (OMB) on a final regulation to implement the Affordable Care Act’s (ACA) restriction on 340B discounts for orphan drugs purchased by hospitals that became eligible for 340B under health care reform, a HRSA spokesperson said this … [Read more...]
Fewer 340B Audits Due to Sequestration?
HRSA says number isn't final, but sources say it's in the 50 to 75 rangeApril 26, 2013—The Health Resources and Services Administration (HRSA) might have to significantly reduce the number of audits of 340B covered entities it plans to perform this year due to automatic federal spending cuts that began on March 1. During a December meeting of hospital pharmacists, Office of Pharmacy Affairs (OPA) Director Cmdr. Krista Pedley said there would be … [Read more...]
Georgia 340B Hospital in Crosshairs After Remarks on TV
Lawmakers say official's comments on Fox program prompted inquiryApril 22, 2013—Two members of Congress have written to a Georgia 340B hospital after one of its officials appeared on national television to respond to a drug industry white paper that alleges misuse of the program. Sen. Charles Grassley (R-Iowa) and Rep. Bill Cassidy (R-La.) sent a letter to Columbus (Ga.) Regional Healthcare System on April 18 seeking information by May 2 … [Read more...]